Journal of Blood Research & Hematologic Diseases

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

deneme bonusu veren siteler

Hans Carl Hasselbalch Author

Subjects of specialization
HTLV-I, Retinoid, Senescence, Redox, ROS

Affiliation
Department of Hematology, National Hospital Organization Osaka Minami Medical Center, Osaka, Japan

Biography

Yasuhiro Maeda is a researcher for blood and hematologic diseases. Published more number of articles which is usefull for blood cancer. Uchiyama T, Yodoi J, Sagawa K, Maeda Y, Yamaguchi T, Hijikata Y, Tanaka M, Hirase C, et al. (2008)Clinical efficacy of all-trans retinoic acid for treating adult T-cell leukemia. J Cancer Res ClinOncol134: 673-677.Takatsuki K, Uchino H (1977) Adult T cell leukemia: Clinical and hematological features of 16 cases. Blood 50: 481-492.,


Publications

Editorial Open Access

Optimal Therapy for Polycythemia Vera and Essential Thrombocythemia: A Different Perspective

Author(s):

Richard T Silver and Hans Carl Hasselbalch

Recent publications have de-emphasized the importance of recombinant interferon alpha (rIFNα) for the treatment of polycythemia vera (PV) or essential thrombocythemia (ET), favoring the use of phlebotomy and/or hydroxyurea. Here we express our reasons for the use of rIFNα early in the course of PV or ET in the absence of a phase 3 trial.

... view moreĀ»

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP